Prospective Study of White Blood Cells

Quell Therapeutics

Status: Enrolling

Conditions: Inflammation; Rejection; Transplant, Liver; Autoimmune Diseases

Treatments: Other: White blood cell and blood collection

Study type: Observational

Funder types: Industry

Identifiers

NCT04838171

QEL-RP-001

Details and patient eligibility

About

The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.

Enrollment: 10 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

No additional inclusion/ exclusion criteria will be applied by Quell other than those specified by the consenting institutions.

Trial design

10 participants in 1 patient group

Specimen collection to support development of engineering Treg

Treatment:

Other: White blood cell and blood collection